Fingerprint
Dive into the research topics of 'Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study
Ian W. Flinn, Manish Patel, Yasuhiro Oki, Steven Horwitz, Francine F. Foss, Kerstin Allen, Mark Douglas, Howard Stern, Jennifer Sweeney, Jahnavi Kharidia, Patrick Kelly, Virginia M. Kelly, Brad Kahl
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations